$Increased fracture risk after discontinuation of anti‐osteoporosis medications among hip fracture patients: A population‐based cohort study$

Increased fracture risk after discontinuation of anti‐osteoporosis medications among hip fracture patients: A population‐based cohort study

Background To compare the risks of major osteoporotic, vertebral, and non‐vertebral fractures between patients who discontinued anti‐osteoporosis medications. Methods We conducted a comparative effectiveness study with a nationwide population‐based cohort study design. Patients aged ≥50 years admitt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of internal medicine 2021-12, Vol.290 (6), p.1194-1205
Hauptverfasser:	Fu, Shau‐Huai, Wang, Chen‐Yu, Hung, Chih‐Chien, Lee, Chia‐Che, Yang, Rong‐Sen, Huang, Chuan‐Ching, Farn, Chui‐Jia, Lin, Wei‐Hsin, Chen, Ho‐Min, Hsiao, Fei‐Yuan, Lin, Jou‐Wei, Li, Chung‐Yi
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical materials bisphosphonate Bisphosphonates Bone Density Conservation Agents - administration & dosage Cohort analysis Cohort Studies Confidence intervals denosumab Denosumab - administration & dosage Diphosphonates - administration & dosage discontinuation Fractures Hip Hip Fractures - epidemiology Hip Fractures - prevention & control Humans Monoclonal antibodies Osteoporosis Osteoporosis - drug therapy Osteoporosis - epidemiology Osteoporotic Fractures - epidemiology Osteoporotic Fractures - prevention & control Patients Population studies Population-based studies Risk Spinal Fractures - epidemiology Spinal Fractures - prevention & control Statistical models Vertebrae
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!